GCM
PFE icon

Gibraltar Capital Management’s Pfizer PFE Stock Holding History

Gibraltar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,307
Closed -$585K – 67
2023
Q4 		$585K Buy
20,307
+571
+3% +$17.3K 0.25% 60
2023
Q3 		$655K Buy
19,736
+369
+2% +$13K 0.29% 50
2023
Q2 		$710K Buy
19,367
+120
+0.6% +$4.67K 0.31% 47
2023
Q1 		$785K Buy
19,247
+5,755
+43% +$249K 0.37% 38
2022
Q4 		$691K Buy
13,492
+2,154
+19% +$103K 0.33% 41
2022
Q3 		$496K Buy
11,338
+2,566
+29% +$125K 0.25% 48
2022
Q2 		$460K Buy
8,772
+33
+0.4% +$1.68K 0.22% 44
2022
Q1 		$452K Sell
8,739
-7,794
-47% -$404K 0.19% 58
2021
Q4 		$976K Sell
16,533
-6,141
-27% -$304K 0.44% 33
2021
Q3 		$975K Sell
22,674
-296
-1% -$13.1K 0.5% 33
2021
Q2 		$902K Buy
22,970
+153
+0.7% +$5.95K 0.45% 36
2021
Q1 		$828K Buy
+22,817
New +$810K 0.43% 38

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Gibraltar Capital Management's PFE Position: Q1 2024 in Review

Gibraltar Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 20,307 shares — an estimated $585K sold.

Gibraltar Capital Management first reported a position in PFE in Q1 2021 and held it in 12 quarters. The position peaked at $976K in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Gibraltar Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Gibraltar Capital Management sold 20,307 Pfizer shares in Q1 2024, an estimated $585K.
  • Gibraltar Capital Management first reported a position in Pfizer in Q1 2021 and held it in 12 quarters.
  • Gibraltar Capital Management's Pfizer position peaked at $976K in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Gibraltar Capital Management's 13F filing for Q1 2024, filed 7 May 2024.